MoneyWorks4Me

Glenmark Pharmaceuticals issues stock options

10 Dec 2011 Evaluate

Glenmark Pharmaceuticals has informed that the compensation committee of the company, at its meeting held on December 07, 2011 has issued 25,000 stock options to permanent employees pursuant to ESOS 2003. Each option shall be convertible into one equity share of Re. 1 each in one or more tranches.

The above information is part of the company’s filing submitted to the BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..